Introduction
Diagnosis of chronic pancreatitis (CP) is challenging, especially in early stages when typical clinical signs and parenchymal changes are lacking. To date, evaluation by endoscopic ultrasound (EUS) using Rosemont criteria (RC) is the gold standard for the diagnosis of CP, but represents an invasive method with still suboptimal accuracy. Therefore, it is of crucial interest to develop non invasive, widely applicable tests for the diagnosis of CP. Recently the Gemelli chronic pancreatitis ultrasound score (USCP) has been developed to fill this gap (1). Comparable to liver stiffness measurement, transabdominal ultrasound (US) with 2D shear wave elastography (2D SWE) could represent an additional alternative for the diagnosis of CP. It uses measurement of tissue stiffness, which increases naturally with chronic inflammatory changes, present in CP (2).
Aims & Methods
We conducted a single center prospective case control study where all the included subjects underwent EUS first (for the suspicious of CP or other reasons such as lithiasis), with RC defined patient cohorts with chronic pancreatitis or absence of parenchymal changes. Patients with and without CP subsequently underwent US with evaluation of the pancreas using 2D SWE (in m/s) and characterization by the USCP score (LogiqE10, GE Healthcare). Primary outcome was agreement between the different evaluation techniques, namely RC and 2D SWE. Secondary outcome was the evaluation of a cut off value of SWE differentiating values in CP from normal values. Main exclusion criteria were patients with liver cirrhosis, acute pancreatitis and inability to visualize the pancreas with US.
Results
51 patients with CP and 51 without CP were included. Median SWE were statistically different between groups (no CP 1.50m/s; IQR 1.34-1.63 and with CP 1.83 m/s; IQR 1.68-2.08; p<0.0001). Patients with RC indeterminate for CP had lower SWE values compared to patients with RC consistent with CP (Median 1.67m/s, IQR 1.52-1.72 vs. 1.90 m/s, IQR 1.72-2.12, p<0.0001). Median USCP Score significantly differed between groups (no CP 0-1 points, with CP 3-9 points, p<0.0001). SWE values did not correlate with age, BMI, HbA1c or stool elastase levels, but correlated significantly with USCP score (p<0.001) and RC (p<0.001). USCP Score significantly correlated with BMI (p=0.011), stool elastase levels (p<0.001), HbA1c (p=0.002) as well as RC (p<0.0001). We defined a cutoff- SWE value of <1.42 m/s to rule out CP with a sensitivity of 97% (NPV 98%) and a SWE cut off >1.97 ms/s to diagnose CP with a specificity of 97% (PPV 92%).
Conclusion
Transabdominal ultrasound evaluation of the pancreas with 2D SWE is a promising, widely applicable and non-invasive tool for the diagnosis of CP. More studies with larger cohorts confirming the results are necessary.
References
1)Pagliari D, et al. A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The 'Gemelli USCP score'. Dig Liver Dis. 2020 Jun;52(6):644-650.
2) Yashima Y et al. Acoustic radiation force impulse elastography for noninvasive assessment of chronic pancreatitis. J Gastroenterol. 2012 Apr;47(4):427-32.